Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

517 ARTÍCULOS , VIENDO DEL 451 AL 465

How far is the goal of applying β-amyloid in cerebrospinal fluid for clinical diagnosis of Alzheimer's disease with standardization of measurements?

Zou Y, Yu S, Ma X, Ma C, Mao C, Mu D, Li L, Gao J, Qiu L.

Clin Biochem. 2023 Feb;112:33-42. doi: 10.1016/j.clinbiochem.2022.11.013. Epub 2022 Dec 5.

A review of novel Cognitive Challenge Tests for the assessment of preclinical Alzheimer's disease

Curiel Cid RE, Matias-Guiu JA, Loewenstein DA.

Neuropsychology. 2023 Sep;37(6):661-672. doi: 10.1037/neu0000883. Epub 2022 Dec 8.

Altered cerebral blood flow in older adults with Alzheimer's disease: a systematic review

Swinford CG, Risacher SL, Wu YC, Apostolova LG, Gao S, Bice PJ, Saykin AJ.

Brain Imaging Behav. 2023 Apr;17(2):223-256. doi: 10.1007/s11682-022-00750-6. Epub 2022 Dec 9.

CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease

Kurihara M, Komatsu H, Sengoku R, Shibukawa M, Morimoto S, Matsubara T, Arakawa A, Orita M, Ishibashi K, Mitsutake A, Shibata S, Ishiura H, Adachi K, Ohse K, Hatano K, Ihara R, Higashihara M, Nishina Y, Tokumaru AM, Ishii K, Saito Y, Murayama S, Kanemaru K, Iwata A.

Neurology. 2023 Mar 7;100(10):e1009-e1019. doi: 10.1212/WNL.0000000000201647. Epub 2022 Dec 14.

Recent diagnostic techniques for the detection of Alzheimer's disease: a short review

Bhujbal SS, Kad MM, Patole VC.

Ir J Med Sci. 2023 Oct;192(5):2417-2426. doi: 10.1007/s11845-022-03244-y. Epub 2022 Dec 16.

Mediterranean diet and structural neuroimaging biomarkers of Alzheimer's and cerebrovascular disease: A systematic review

Gregory S, Pullen H, Ritchie CW, Shannon OM, Stevenson EJ, Muniz-Terrera G.

Exp Gerontol. 2023 Feb;172:112065. doi: 10.1016/j.exger.2022.112065. Epub 2022 Dec 15.

Salivary Aβ(1-42) may be a quick-tested biomarker for clinical use in Alzheimer's disease: a meta-analysis

Fan Z, Li Z, Zhao S, Chen Y, Su Y, Peng G, Luo B.

J Neurol. 2023 Apr;270(4):1945-1954. doi: 10.1007/s00415-022-11509-w. Epub 2022 Dec 23.

Fluid biomarkers in Alzheimer's disease

Simrén J, Elmgren A, Blennow K, Zetterberg H.

Adv Clin Chem. 2023;112:249-281. doi: 10.1016/bs.acc.2022.09.006. Epub 2022 Nov 4.

Elevated sTREM2 and NFL levels in patients with sepsis associated encephalopathy

Orhun G, Esen F, Yilmaz V, Ulusoy C, Şanlı E, Yıldırım E, Gürvit H, Ergin Özcan P, Sencer S, Bebek N, Tüzün E.

Int J Neurosci. 2023 Mar;133(3):327-333. doi: 10.1080/00207454.2021.1916489. Epub 2021 May 4.

A systematic review of the prevalence of depression, anxiety, and apathy in frontotemporal dementia, atypical and young-onset Alzheimer's disease, and inherited dementia

Collins JD, Henley SMD, Suárez-González A.

Int Psychogeriatr. 2023 Sep;35(9):457-476. doi: 10.1017/S1041610220001118. Epub 2020 Jul 20.

Neuroimaging in Dementia

Risacher SL, Apostolova LG.

Continuum (Minneap Minn). 2023 Feb 1;29(1):219-254. doi: 10.1212/CON.0000000000001248.

Depression in dementia with Lewy bodies: a critical update

Jellinger KA.

J Neural Transm (Vienna). 2023 Oct;130(10):1207-1218. doi: 10.1007/s00702-023-02669-8. Epub 2023 Jul 7.

Applications of Artificial Intelligence to Diagnosis of Neurodegenerative Diseases

Feng T.

Stud Health Technol Inform. 2023 Nov 23;308:648-655. doi: 10.3233/SHTI230896.

Race and Ethnicity in Lewy Body Dementia: A Narrative Review

Bayram E, Holden SK, Fullard M, Armstrong MJ; Lewy Body Dementia Association Community Engagement Working Group.

J Alzheimers Dis. 2023;94(3):861-878. doi: 10.3233/JAD-230207.

Advances in Diagnosis and Prognosis of Parkinson Disease: Value of CSF Proteomics

Parnetti L, Bellomo G.

Neurology. 2023 Oct 3;101(14):595-596. doi: 10.1212/WNL.0000000000207724. Epub 2023 Aug 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias